Development of a rapid, robust, and universal picogreen-based method to titer adeno-associated vectors
Abstract
Recombinant adeno-associated viruses (rAAVs) are promising vectors in preclinical and clinical assays for the treatment of diseases with gene therapy strategies. Recent technological advances in amplification and purification have allowed the production of highly purified rAAV vector preparations. Although quantitative polymerase chain reaction (qPCR) is the current method of choice for titrating rAAV genomes, it shows high variability. In this work, we report a rapid and robust rAAV titration method based on the quantitation of encapsidated DNA with the fluorescent dye PicoGreen®. This method allows detection from 3×10(10) viral genome/ml up to 2.4×10(13) viral genome/ml in a linear range. Contrasted with dot blot or qPCR, the PicoGreen-based assay has less intra- and interassay variability. Moreover, quantitation is rapid, does not require specific primers or probes, and is independent of the rAAV pseudotype analyzed. In summary, development of this universal rAAV-titering method may have substantive implications in rAAV technology.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
DyeBAs can directly quantify genome titer from at least crudely purified samples using FS signals.
“Direct quantification of the genome titer from at least crudely purified samples is possible using FS signals from dye-based binding assays (DyeBAs).”
From Analytical methods for process and product characterization of recombinant adeno-associated virus-based gene therapies (2021) · cites this paper as [60]
The citation lists haven’t been fetched yet
References 24 · Cited by 70
- Authors
- Piedra, J., Ontiveros, M., Miravet, S., Penalva, C., Monfar, M., & Chillon, M.
- Affiliations
- Vector Production Unit, Center of Animal Biotechnology and Gene Therapy, Universitat Autònoma de Barcelona, Bellaterra 08193, Barcelona, Spain.
- Universitat Autònoma de Barcelona (ES)
- Venue
- Human Gene Therapy Methods
- Publisher
- SAGE Publications
- Published
- 2015-02
- Volume
- 26
- Issue
- 1
- Pages
- 35-42
- ISSN
- 1946-6536 (ISSN-L)
- 1946-6544
- OpenAlex
- W1177905050
- Cited by
- 70
- References
- 24
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 7 · 2023: 7 · 2022: 10 · 2021: 8 · 2020: 5 · 2019: 5 · 2018: 5 · 2017: 9 · 2016: 2 · 2015: 2
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Gene Therapy Methods (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Keywords
- PicoGreen, gene therapy vectors, assay variability
- MeSH terms
- Dependovirus, Genetic Vectors, Humans, Organic Chemicals, Titrimetry, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review